Elevated levels of interleukin-6 (IL-6), IL-17, IL-23, or tumor necrosis factor-alpha (TNF α) have been detected at higher concentrations in the blood and/or ocular fluids of patients with uveitis of various etiologies; and most therapeutic targets in recent decades have involved these cytokine pathways [4]. The gene discussed is IL6; the disease is uveitis.